Abstract:Highlights • We propose a novel drug repurposing approach, which integrates gene expression profile and gene regulatory network to compute inhibition score using the shortest distance in the tissue-specific network, called DRIE. • Experimental results on multiple datasets indicate that DRIE outperforms state-of-the-art methods for cancer drug repurposing prediction. • Case studies show that our method can effectively discover novel drug-disease associations. Numerous computational drug repurposing methods have emerged as efficient alternatives to costly and time-consuming traditional drug discovery approaches. Some of these methods are based on the assumption that the candidate drug should have a reversal effect on disease-associated genes. However, such methods are not applicable in the case that there is limited overlap between disease-related genes and drug-perturbed genes. In this study, we proposed a novel D rug R epurposing method based on the I nhibition E ffect on gene regulatory network ( DRIE ) to identify potential drugs for cancer treatment. DRIE integrated gene expression profile and gene regulatory network to calculate inhibition score by using the shortest path in the disease-specific network. The results on eleven datasets indicated the superior performance of DRIE when compared to other state-of-the-art methods. Case studies showed that our method effectively discovered novel drug-disease associations. Our findings demonstrated that the top-ranked drug candidates had been already validated by CTD database. Additionally, it clearly identified potential agents for three cancers (colorectal, breast, and lung cancer), which was beneficial when annotating drug-disease relationships in the CTD. This study proposed a novel framework for drug repurposing, which would be helpful for drug discovery and development. Availability and implementation The source code of our method is freely available at https://github.com/eshinesimida/DRIE. Graphical abstract Download : Download high-res image (178KB) Download : Download full-size image

Integrating population-level and cell-based signatures for drug repositioning

DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer

Gene Signature-Based Drug Repositioning

A Pathway Profile-Based Method for Drug Repositioning

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity

Computational drug repositioning: from data to therapeutics.

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression

In silico drug repositioning based on drug-miRNA associations

ReDisX, a machine learning approach, rationalizes rheumatoid arthritis and coronary artery disease patients uniquely upon identifying subpopulation differentiation markers from their genomic data

Drug Repositioning For Diabetes Based On 'Omics' Data Mining

A drug repurposing method based on inhibition effect on gene regulatory network

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

deepDR: a network-based deep learning approach to in silico drug repositioning

Integrated edge information and pathway topology for drug-disease associations

An integrated computational strategy to predict personalized cancer drug combinations by reversing drug resistance signatures

Discovery of Novel Therapeutic Properties of Drugs from Transcriptional Responses Based on Multi-Label Classification

EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy.